Companies

Glaukos Corporation

NYSE: GKOS
$177.47
▼ $2.88 (−1.60%) today
Markets closed · 10:35pm ET
Today · % change

24/7 Wall St. View

About Glaukos

Glaukos Corporation is a pioneer in eye care, focusing on innovative treatments for glaucoma, corneal disorders, and retinal diseases. Known for its iStent products, which are tiny stents used in cataract surgery to help manage glaucoma, the company is also developing new solutions like the iStent Infinite for severe glaucoma cases and iDose TR for reducing eye pressure. With a commitment to improving patients' vision and quality of life, Glaukos markets its products globally, combining medical technology with pharmaceutical therapies since its founding in 1998 in Aliso Viejo, California.

GKOS Coverage